Optellum Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
52
- Latest Deal Type
-
Series B
- Investors
-
14
Optellum General Information
Description
Developer of a clinical software designed to diagnose lung cancer and treat it at an early stage. The company's software identifies at-risk patients and expedites optimal therapy for patients with cancer, as well as captures patients with incidental nodules through automated analysis of radiology reports, enabling physicians to manage their patients in an optimal way.
Contact Information
Website
www.optellum.comCorporate Office
- 5 Kings Meadow, Osney Mead
- Ferry Hinksey Road
- Oxford OX2 0DP
- England, United Kingdom
Corporate Office
- 5 Kings Meadow, Osney Mead
- Ferry Hinksey Road
- Oxford OX2 0DP
- England, United Kingdom
Optellum Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series B) | 08-Jan-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A) | 01-Jun-2025 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 19-Mar-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 24-Aug-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 06-Jun-2019 | Completed | Generating Revenue | |||
| 5. Seed Round | 08-May-2019 | Completed | Generating Revenue | |||
| 4. Seed Round | 30-Jun-2017 | Completed | Generating Revenue | |||
| 3. Grant | 01-Dec-2016 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Optellum Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| A4 Ordinary | ||||||||
| A3 Ordinary | ||||||||
| A2 Ordinary | ||||||||
| A1 Ordinary | ||||||||
| A1 Ordinary | ||||||||
| Ordinary | 69,255,960 | $0.000001 | $0.06 | $0.06 | 1x | $0.06 | 16.8% | |
| Ordinary | 57,142,858 | $0.000001 | $0.02 | $0.02 | 1x | $0.02 | 13.86% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Optellum Comparisons
Industry
Financing
Details
Optellum Competitors (11)
One of Optellum’s 11 competitors is SigTuple, a Venture Capital-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SigTuple | Venture Capital-Backed | Bengaluru, India | ||||
| Strata Oncology | Venture Capital-Backed | Ann Arbor, MI | ||||
| Epic Sciences | Venture Capital-Backed | San Diego, CA | ||||
| Inspirata | Private Debt Financed | Tampa, FL | ||||
| ScreenPoint Medical | Venture Capital-Backed | Nijmegen, Netherlands |
Optellum Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Optellum Patents
Optellum Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4787387-A1 | System and method for language agnostic patient discovery | Pending | 03-Feb-2025 | ||
| US-20260228261-A1 | System and method for language agnostic patient discovery | Pending | 03-Feb-2025 | ||
| US-20260018285-A1 | System and method to aid clinicians in accessing the outcome of lung cancer interventions | Pending | 11-Jul-2024 | ||
| EP-4679452-A1 | System and method to aid clinicians in assessing the outcome of lung cancer interventions | Pending | 11-Jul-2024 | ||
| EP-4657453-A1 | System and method for automation of patient discovery and workflow distribution | Pending | 29-May-2024 | G16H40/20 |
Optellum Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Optellum Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Healthliant Ventures | Venture Capital | Minority | ||
| Woori Venture Partners | Venture Capital | Minority | ||
| The NHS Innovation Accelerator | Accelerator/Incubator | |||
| Black Opal Ventures | Venture Capital | Minority | ||
| Intuitive Ventures | Corporate Venture Capital | Minority |
Optellum FAQs
-
When was Optellum founded?
Optellum was founded in 2015.
-
Where is Optellum headquartered?
Optellum is headquartered in Oxford, United Kingdom.
-
What is the size of Optellum?
Optellum has 52 total employees.
-
What industry is Optellum in?
Optellum’s primary industry is Decision/Risk Analysis.
-
Is Optellum a private or public company?
Optellum is a Private company.
-
What is Optellum’s current revenue?
The current revenue for Optellum is .
-
How much funding has Optellum raised over time?
Optellum has raised $25.3M.
-
Who are Optellum’s investors?
Healthliant Ventures, Woori Venture Partners, The NHS Innovation Accelerator, Black Opal Ventures, and Intuitive Ventures are 5 of 14 investors who have invested in Optellum.
-
Who are Optellum’s competitors?
SigTuple, Strata Oncology, Epic Sciences, Inspirata, and ScreenPoint Medical are some of the 11 competitors of Optellum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
